Quantity size:
0.2ml
Concentration:
1mg/ml 细胞核因子/k基因结合核因子 p52/p100抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
NFkB is formed through the association of multiple subunits, either as a homodimer or heterodimer. Subunits have been identified as p50 (NFkB1), p65 (RelA), c-Rel, RelB and p52 (NFkB2). The classic NFkB form exists as a p50-p65 heterodimer and predominates in many cell types. Many of the possible combinatorial forms of homo- and heterodimers have been identified and growing evidence indicates that different forms of NFkB have different functions in cells. Interestingly, both the p50 and p52 subunits are derived from theV precursor proteins p105 and p100 respectively, that each contain multiple copies of the so called ankyrin repeat at their C termini. Nuclear translocation of NFkB is confirmed by the use of electrophorectic mobility shift assays or by immunoblotting with nuclear extracts. The subunit composition of NFkB is confirmed by the use of antibodies that "supershift" the DNA/protein complex.
细胞核因子/k基因结合核因子 p52/p100抗体Also known as:
NFkB p100; p52; NFKB p52; NFkB p100 / p52; DNA binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lyt10; Oncogene Lyt 10; DNA binding factor KBF2; DNA-binding factor KBF2; H2TF1; Lymphocyte translocation chromosome 10; Lymphocyte translocation chromosome 10 protein; Lyt 10; Lyt10; NFKB2; NFKB2_HUMAN; Nuclear factor NF kappa B p100 subunit; Nuclear factor NF kappa B p52 subunit; Nuclear factor NF-kappa-B p52 subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 2;细胞核因子/k基因结合核因子 p52/p100抗体 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2; Oncogene Lyt 10; Oncogene Lyt-10; p49/p100.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human NFKB p52.
●
细胞核因子/k基因结合核因子 p52/p100抗体Predicted Molecular Weight: 50/ 100kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl819Ra01甲状旁腺激素相关蛋白(PTHrP)多克隆抗体Polyclonal Antibody to klathyroid Hormone Related Protein (PTHrP)
kl822Ga0160kD热休克蛋白(HSPD1)多克隆抗体Polyclonal Antibody to Heat Shock 60kD Protein 1, Chaperonin (HSPD1)
kl822Hu0160kD热休克蛋白(HSPD1)多克隆抗体Polyclonal Antibody to Heat Shock 60kD Protein 1, Chaperonin (HSPD1)
kl822Mu0160kD热休克蛋白(HSPD1)多克隆抗体Polyclonal Antibody to Heat Shock 60kD Protein 1, Chaperonin (HSPD1)
kl822Ra0160kD热休克蛋白(HSPD1)多克隆抗体Polyclonal Antibody to Heat Shock 60kD Protein 1, Chaperonin (HSPD1)
kl823Bo0190kDa热休克蛋白β1(HSP90β1)多克隆抗体Polyclonal Antibody to Heat Shock Protein 90kDa Beta 1 (HSP90b1)
kl823Hu0190kDa热休克蛋白β1(HSP90β1)多克隆抗体Polyclonal Antibody to Heat Shock Protein 90kDa Beta 1 (HSP90b1)
kl823Mu0190kDa热休克蛋白β1(HSP90β1)多克隆抗体Polyclonal Antibody to Heat Shock Protein 90kDa Beta 1 (HSP90b1)
kl823Ra0190kDa热休克蛋白β1(HSP90β1)多克隆抗体Polyclonal Antibody to Heat Shock Protein 90kDa Beta 1 (HSP90b1)
kl824Hu01B-淋巴细胞激活抗原B7-2(LAB7-2)多克隆抗体Polyclonal Antibody to B-Lymphocyte Activation Antigen B7-2 (LAB7-2)
kl827Mu01肿瘤坏死因子配体超家族成员14(TNFSF14)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 14 (TNFSF14)
kl829Hu01免疫球蛋白G3(IgG3)多克隆抗体Polyclonal Antibody to Immunoglobulin G3 (IgG3)
kl833Ca01血管性血友病因子(vWF)多克隆抗体Polyclonal Antibody to Von Willebrand Factor (vWF)
kl833Po01血管性血友病因子(vWF)多克隆抗体Polyclonal Antibody to Von Willebrand Factor (vWF)
kl833Rb51血管性血友病因子(vWF)多克隆抗体Polyclonal Antibody to Von Willebrand Factor (vWF)
kl834Hu01凝血因子Ⅹ(F10)多克隆抗体Polyclonal Antibody to Coagulation Factor X (F10)
kl834Mu01凝血因子Ⅹ(F10)多克隆抗体Polyclonal Antibody to Coagulation Factor X (F10)
kl834Ra01凝血因子Ⅹ(F10)多克隆抗体Polyclonal Antibody to Coagulation Factor X (F10)
kl837Ca01诱导型一氧化氮合酶(NOS2)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl837Hu01诱导型一氧化氮合酶(NOS2)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl837Mu01诱导型一氧化氮合酶(NOS2)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl837Ra01诱导型一氧化氮合酶(NOS2)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl837Rb51诱导型一氧化氮合酶(NOS2)多克隆抗体Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl838Hu01抑制素βA(INHβA)多克隆抗体Polyclonal Antibody to Inhibin Beta A (INHbA)
kl838Ra01抑制素βA(INHβA)多克隆抗体Polyclonal Antibody to Inhibin Beta A (INHbA)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话